DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Berek J et al.
Oregovomab maintenance monoimmunotherapy does not improve outcomes in advanced
ovarian cancer.
J Clin Oncol 2009;
27: 418-425
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.